Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

129.49
BATS BZX Real-Time Price
As of 3:14pm ET
 +2.77 / +2.19%
Today’s Change
67.81
Today|||52-Week Range
131.12
+43.43%
Year-to-Date
Nevro Hits New 52-Week High on Solid HF10 Therapy Sales
Sep 26 / Zacks.com - Paid Partner Content
CryoLife Hits a 52-Week High on Strong Growth Prospects
Sep 23 / Zacks.com - Paid Partner Content
Patterson Companies Faces Multiple Issues: Dump Now?
Sep 26 / Zacks.com - Paid Partner Content
Thermo Fisher Adds FEI Co., Inorganic Expansion Continues
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close126.72
Today’s open127.11
Day’s range126.56 - 131.12
Volume37,448
Average volume (3 months)508,535
Market cap$5.5B
Dividend yield--
Data as of 3:14pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+37.91%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+43.09%
P/E ratio137.9
Price/Sales12.92
Price/Book14.64

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+1.72+2.40%
TFXTeleflex Inc+0.48+0.29%
CMNCantel Medical Corp-0.07-0.09%
NUVANuVasive Inc+0.88+1.33%
Data as of 3:14pm ET, 09/27/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.24
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Search for Jobs